← Research library

The influence of polypeptide liver complex and tetrapeptide KEDA on organism physiological function in norm and age-related pathology

Review of earlier studies · 2020

What was studied
Animal and in-vitro liver pathology models
Main finding
Reviews liver polypeptide complex Ventvil and KEDA/Livagen in experimental fibrosis and hepatitis, with immune and antioxidant outcomes.

Study data at a glance

Participants or experimental model
Animal and in-vitro liver pathology models
Reported results
Reviews liver polypeptide complex Ventvil and KEDA/Livagen in experimental fibrosis and hepatitis, with immune and antioxidant outcomes.
Study limitations and source details

Study limitations

  • Extract and tetrapeptide are separate interventions.
  • This is a review of experimental models, not a clinical hepatitis treatment trial.

Source details

Indexed abstract and citation checked via Europe PMC / PubMed; full methods and risk of bias not appraised.

Sources checked

Citation

Author affiliations · St. Petersburg Institute of Bioregulation and Gerontology

ReviewEnglish abstract

Kuznik BI, Khasanova NB, Ryzhak GA, Mezsheriakova IE, Khavinson VK. The influence of polypeptide liver complex and tetrapeptide KEDA on organism physiological function in norm and age-related pathology Adv Gerontol 33(1):159-164. PMID 32362099

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards